|
Market Closed -
Other stock markets
|
After hours 06:06:29 pm | |||
| 367.99 USD | -0.03% |
|
361.34 | -1.81% |
| Jul. 08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| Jul. 08 | Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating | MT |
| Market Cap | 199B 174B 161B 148B 282B 18,982B 287B 1,925B 749B 9,307B 746B 730B 32,302B | P/E 2026 * |
24.1x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 241B 211B 195B 180B 341B 23,001B 347B 2,332B 907B 11,278B 904B 884B 39,143B | EV / Sales 2026 * |
6.37x | EV / Sales 2027 * | 6.08x |
| Free-Float |
99.78% | Yield 2026 * |
2.74% | Yield 2027 * | 2.9% |
Last Transcript: Amgen Inc.
| 1 day | -1.81% | ||
| 1 week | +1.62% | ||
| Current month | +1.62% | ||
| 1 month | +5.27% | ||
| 3 months | +8.23% | ||
| 6 months | +7.71% | ||
| Current year | +12.43% |
| 1 week | 359.47 |  | 375.25 |
| 1 month | 334.05 | | 375.25 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 218.61 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | +1.62% | +25.62% | +68.30% | 199B | |
| -1.60% | +1.37% | +57.31% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.64% | +65.40% | 643B | |
| -0.75% | +0.44% | +34.70% | +86.52% | 450B | |
| -1.35% | +0.63% | +30.26% | +26.28% | 336B | |
| -0.86% | +0.99% | +39.36% | +40.85% | 298B | |
| -0.71% | -0.54% | +28.98% | +48.27% | 288B | |
| -1.31% | +2.72% | -26.76% | -39.82% | 222B | |
| -0.40% | +7.50% | +21.51% | +82.50% | 169B | |
| -0.08% | -0.12% | -4.71% | -32.31% | 137B | |
| Average | -0.67% | +2.22% | +27.59% | +51.49% | 384.32B | |
| Weighted average by Cap. | -0.47% | +2.06% | +40.58% | +82.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.77B 33.09B 30.53B 28.21B 53.53B 3,609B 54.5B 366B 142B 1,770B 142B 139B 6,142B | 38.7B 33.9B 31.28B 28.9B 54.84B 3,698B 55.84B 375B 146B 1,813B 145B 142B 6,293B |
| Net income | 8.23B 7.21B 6.65B 6.15B 11.66B 786B 11.88B 79.74B 31.03B 386B 30.91B 30.23B 1,338B | 8.86B 7.76B 7.16B 6.62B 12.56B 847B 12.79B 85.88B 33.42B 415B 33.29B 32.56B 1,441B |
| Net Debt | 42.07B 36.85B 34B 31.42B 59.61B 4,019B 60.7B 408B 159B 1,971B 158B 155B 6,840B | 36.52B 31.98B 29.51B 27.27B 51.74B 3,489B 52.69B 354B 138B 1,711B 137B 134B 5,937B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | $367.99 | -0.03% | 1,729,319 |
| 26-07-07 | $368.10 | +0.45% | 1,983,666 |
| 26-07-06 | $366.44 | -2.06% | 2,838,007 |
| 26-07-02 | $374.15 | +3.55% | 2,487,837 |
| 26-07-01 | $361.33 | -0.22% | 2,244,791 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
